Kidney Transplant Rejection
📧 Sign up to get email alerts when something new happens for Kidney Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients [Phase 1, Phase 2]
Phase 1/2 trial results assess safety and tolerability of a chimeric antigen receptor T-regulatory cell therapy in living donor renal transp…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) [Phase 3]
Phase 3 clinical trial evaluating the safety and effects of felzartamab infusions in adults with antibody-mediated rejection after kidney tr…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation [Phase 2, Phase 3]
A clinical trial comparing Frexalimab to Tacrolimus in adult kidney transplant recipients is in Phase 2/Phase 3 and currently recruiting, ev…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) [Phase 3]
A Phase 3 clinical trial updating on long-term safety and effects of felzartamab infusions in adults with kidney transplants experiencing an…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation [Phase 2]
A Phase 2 clinical trial by Biogen is evaluating felzartamab infusions in adults with kidney transplants who have late isolated microvascula…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: The smartNTx Trial:Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR) [NA]
The smartNTx trial is evaluating telemedical management versus standard aftercare in kidney transplant recipients; the study is currently ac…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Belimumab to Mobilise Memory B-cells From Secondary Lymhoid Organs to Improve Memory B-cell HLA-specificity Profiling to Support Delisting for Transplant Access in Highly-sensitized [Phase 2]
Phase 2 study evaluating Belimumab to mobilize memory B-cells and improve HLA-specificity profiling for delisting to access transplanted kid…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) [Phase 3]
Phase 3 study to assess long-term safety and effects of felzartamab infusions in adults with antibody-mediated rejection after kidney transp…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients [Phase 3]
Phase 3 clinical trial investigating treatment of BK polyomavirus infection in kidney and simultaneous kidney-pancreas transplant recipients…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing frexalimab to tacrolimus in adults undergoing kidney transplantation is currently recruiting to assess eff…
-
FDA approval · 2026-03-18FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for mycophenolate mofetil from Aurobindo Pharma Limited under an ANDA.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity
A recruiting clinical study evaluating peripheral and intrarenal B cells in antibody-mediated rejection after kidney transplantation, focusi…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Trifecta-Kidney cfDNA-MMDx Study
A University of Alberta-led clinical trial is currently recruiting to evaluate the trifecta-kidney cfDNA-MMDx diagnostic approach for kidney…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) [Phase 3]
A Phase 3 study is evaluating the safety and effects of felzartamab infusions in adults with antibody-mediated rejection after kidney transp…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Treatment of Antibody-Mediated Rejection (ABMR) With CarBel [Phase 2]
Phase 2 clinical trial evaluating CarBel for treating antibody-mediated rejection in kidney transplant recipients; currently not yet recruit…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: (TNX-1500) in Kidney Transplant Recipients [Phase 2]
A Phase 2 clinical trial update for TNX-1500 in kidney transplant recipients, with the study status listed as NOT_YET_RECRUITING.
-
FDA approval · 2026-02-23FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's supplemental application for Mycophenolate mofetil (generic) under the ANDA, approving chan…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Torque Teno Virus: A Biomarker of Immunosuppression
An update on a completed clinical trial evaluating Torque Teno Virus as a biomarker of immunosuppression in kidney transplant recipients, wi…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA
A clinical trial is evaluating urinary CXCL10 as a biomarker to improve detection of acute kidney allograft rejection in kidney transplant p…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R) [Phase 2, Phase 3]
A Phase 2/3 clinical trial (BELA-M-R) is evaluating belatacept for prevention of subclinical antibody-mediated rejection after kidney transp…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Bortezomib in Rejection of Kidney Transplants [Phase 2]
Phase 2 trial evaluating bortezomib for chronic antibody-mediated rejection in kidney transplants has completed.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab [NA]
The document reports that a clinical trial evaluating tocilizumab for chronic active antibody-mediated rejection in kidney transplant patien…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Using MSCs for Chronic Active Antibody Mediated Rejection [NA]
A clinical trial entry evaluating mesenchymal stem cell therapy for chronic active antibody-mediated rejection in kidney transplant recipien…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection
An observational study in Scotland led by the University of Edinburgh to identify predictors and improve diagnosis of kidney transplant reje…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function [NA]
This clinical trial update describes the AIIM trial, which investigates a personalized medicine approach to kidney allograft function in kid…